Aurobindo Pharma today announced the completion of acquisition of assets of nutritional supplement maker, Natrol and other affiliate entities through its wholly owned subsidiary Aurobindo Pharma USA (APUSA).

APUSA emerged as the highest and best bidder to acquire assets of Natrol under the auction process by the United States Bankruptcy Court for the District of Delaware was previously announced on Nov. 12, 2014.

APUSA acquired the manufacturing assets, personnel, commercial infrastructure including the well established nutraceuticals brands in USA of Natrol along with an agreement to take on certain liabilities, with a bid of USD 132.5 million. The assets have been acquired under a wholly owned subsidiary 'Nature Acquisition' and since changed to Natrol. The final terms of acquisition are the same as originally envisaged during announcement made earlier. APUSA expects the profitability to improve by combining the strength of both enterprises in creating a fully integrated nutraceuticals platform in the USA and other international markets.

N Govindarajan, managing director of Aurobindo said, "Natrol comes with certain well established brands and an extensive distribution network consisting of retail pharmacy chains and specialty health food stores, to help us tactically position ourselves in the US nutraceuticals space and offer an effective growth strategy to expand market penetration going forward."

Shares of the company declined Rs 7.7, or 0.68%, to settle at Rs 1,123.60. The total volume of shares traded was 44,619 at the BSE (Friday).